IONIS PHARMACEUT reported $34.13M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Astellas Pharma 4503:JP 153.4B 10.98B
Biocryst Pharmaceuticals BCRX:US $ 38.02M 3.74M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bluebird Bio BLUE:US $ 36.69M 588K
Esperion Therapeutics ESPR:US $ 29.61M 772K
Exelixis EXEL:US $ 102.86M 3.55M
Halozyme Therapeutics HALO:US $ 13.83M 60K
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
Mirati Therapeutics MRTX:US $ 54.23M 277K
Moderna Inc MRNA:US 211M 57M
Nektar Therapeutics NKTR:US $ 21.44M 5.9M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K